Survivor-Sleep Health Information Program

Sponsor
Dana-Farber Cancer Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT04863157
Collaborator
Children's Cancer Research Fund (Other)
20
1
1
19.3
1

Study Details

Study Description

Brief Summary

The purpose of the study is to learn if an educational program delivered to parents/guardians can help improve the sleep of children experiencing sleep problems after completing cancer treatment. The name of the intervention is Survivor-SHIP (Sleep Health Information Program).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Survivor-SHIP
N/A

Detailed Description

This study will evaluate Survivor-SHIP in a single-arm trial of 20 off-treatment childhood cancer survivors (ages 5-12). The intervention is an adapted version of the family-centered Sleep Health Program designed at Seattle Children's Hospital. The program offers parents information about how to utilize evidence-based strategies for their child's sleep, and has demonstrated success in a community-based sample of children with behavioral sleep problems. Sessions will focus on providing parents with education about healthy sleep and setting targets for modifiable behaviors that can improve their child's sleep health.

The study will include 3 education sessions taking place over videoconference. Families will be asked to track their child's sleep using sleep diaries during the course of the program. Prior to, and following the program, families will be asked to complete study questionnaires.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Sleep Intervention for Children After Cancer: Survivor Sleep Health Information Program (Survivor-SHIP)
Actual Study Start Date :
May 24, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Survivor-SHIP

Parents/guardians will take part in 3 education sessions over a one month period. During the sessions, they will learn more about common sleep problems following cancer treatment and ways to understand their child's unique patterns. They will then be educated about behavioral changes they can make to improve their child's sleep.

Behavioral: Survivor-SHIP
Parent/guardian education about healthy sleep practices to improve their child's sleep health.
Other Names:
  • Survivor-Sleep Health Information Program
  • Outcome Measures

    Primary Outcome Measures

    1. Intervention acceptability [6 weeks]

      Intervention acceptability will be assessed using the Satisfaction subscale of the Usability, Satisfaction, and Ease of use (USE) scale. Total scores will range from 0-11, with higher scores indicating better acceptability.

    2. Intervention feasibility [6 weeks]

      Intervention feasibility will be assessed based on adherence rates to the intervention sessions.

    Secondary Outcome Measures

    1. Sleep knowledge [6 weeks]

      The Parent Sleep Knowledge questionnaire is a 10-item questionnaire assessing the parents' knowledge about children's sleep. The scale is scored from 0 to 10, with a higher score indicating more knowledge.

    2. Sleep habits [6 weeks]

      The Children's Sleep Habits Questionnaire (CSHQ) is a 33-item questionnaire that will assess the child's overall sleep habits. A Total Sleep Disturbances score is calculated as the sum of all scored questions, and can range from 33 to 99, with higher scores indicating more sleep disturbance.

    3. Sleep quality [6 weeks]

      The Patient-reported outcomes measurement information system (PROMIS) pediatric sleep scales are an 8-item measure that assesses the child's sleep quality. A total score will range from 8 to 40, with higher scale scores indicating poorer sleep health

    4. General quality of life [6 weeks]

      The child's quality of life will be evaluated by the Pediatric Quality of Life Inventory (PedsQL), a 23-item scale measuring core physical, mental, and social health dimensions. Scores are transformed on a scale from 0 to 100, with higher scores indicating better function.

    5. Screen time [6 weeks]

      The extent of the child's electronic screen use will be assessed by a set of 9 questions that were developed specifically for this study by the Principal Investigator. They assess the duration of electronics usage across different devices and timing of usage.

    6. Sleep change [6 weeks]

      The investigators will assess whether the family implemented any non-intervention advised changes to their child's sleep routine, such as increasing medication for their sleep during the intervention period. This set of 5 questions will be assessed only at the post-intervention timepoint.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Child aged 5-12 years, with a history of a cancer diagnosis (except non-melanoma skin cancer).

    • No cancer therapy (excluding chemoprevention) in the past 6 months, and no further therapy planned.

    • Child meets diagnostic criteria for insomnia disorder as determined by insomnia screening criteria (see Appendix A)

    • Parent/guardian is able to read and write in English.

    • Regular access to a computer/smartphone with internet access at home.

    Exclusion Criteria:
    • Reports child has been diagnosed with a Seizure Disorder or has experienced a seizure in the past 12 months.

    • Reports child has been diagnosed with a developmental disorder such as Autism Spectrum Disorder, Cerebral Palsy, Fragile X Syndrome, or Moderate to Profound Intellectual Disability.

    • Reports child has been diagnosed with sleep apnea, and are not receiving recommended medical treatment for their sleep apnea.

    • Intention to adjust (decrease or increase) child's use of any prescribed or over-the-counter sleep medications during the study period.

    • Any impairment (e.g., hearing, visual, cognitive) that interferes with the parent/guardian's ability to complete all study procedures independently.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dana-Farber Cancer Institute Boston Massachusetts United States 02215

    Sponsors and Collaborators

    • Dana-Farber Cancer Institute
    • Children's Cancer Research Fund

    Investigators

    • Principal Investigator: Eric Zhou, PhD, Dana-Farber Cancer Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Eric Zhou, Principal Investigator, Dana-Farber Cancer Institute
    ClinicalTrials.gov Identifier:
    NCT04863157
    Other Study ID Numbers:
    • 21-018
    First Posted:
    Apr 28, 2021
    Last Update Posted:
    Jun 28, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Eric Zhou, Principal Investigator, Dana-Farber Cancer Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 28, 2022